AEON Biopharma, Inc. (AEON) — Institutional Holders, Q2 2026
22 institutional investment managers reported a AEON position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $9.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AEON in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Dauntless Investment GroupAdded · +9,962,379 sh+$7.2M
- StoneX GroupNew · +18,953 sh+$13.6K
- GEODE CAPITAL MANAGEMENTAdded · +8,249 sh+$5.9K
- CITIGROUPAdded · +6,573 sh+$4.7K
- Tower Research Capital (TRC)Added · +2,097 sh+$1.5K
Biggest sellers
- XTX Topco LtdSold out · -20,424 sh-$14.7K
- JANE STREET GROUPSold out · -16,376 sh-$11.8K
- VANGUARD FIDUCIARYTrimmed · -989 sh-$711.00
- Vanguard Global AdvisersSold out · -102 sh-$73.00
- MAI Capital ManagementSold out · -58 sh-$42.00
AEON 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Dauntless Investment Group#1 · 12,490,154 sh | 12,490,154 | $9.0M | 7.06% | +394.1% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 95,311 sh | 95,311 | $68.6K | 0.00% | +9.5% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 90,529 sh | 90,529 | $65.1K | 0.00% | 0.0% |
| 4 | Blue Owl Capital#4 · 42,353 sh | 42,353 | $30.5K | <0.01% | 0.0% |
| 5 | Formidable Asset Management#5 · 20,024 sh | 20,024 | $19.7K | <0.01% | 0.0% |
| 6 | StoneX Group#6 · 18,953 sh | 18,953 | $14.9K | <0.01% | New |
| 7 | VANGUARD FIDUCIARY#7 · 13,713 sh | 13,713 | $9.9K | 0.00% | -6.7% |
| 8 | LPL Financial#8 · 11,507 sh | 11,507 | $8.3K | 0.00% | 0.0% |
| 9 | CITIGROUP#9 · 7,315 sh | 7,315 | $5.3K | 0.00% | +885.8% |
| 10 | UBS Group AG#10 · 5,062 sh | 5,062 | $3.6K | 0.00% | +21.0% |
| 11 | BlackRock#11 · 2,834 sh | 2,834 | $2.0K | 0.00% | 0.0% |
| 12 | Tower Research Capital (TRC)#12 · 2,567 sh | 2,567 | $1.8K | 0.00% | +446.2% |
| 13 | Steward Partners Investment Advisory#13 · 1,100 sh | 1,100 | $791.00 | 0.00% | 0.0% |
| 14 | WOLFF WIESE MAGANA#14 · 567 sh | 567 | $408.00 | — | 0.0% |
| 15 | SBI Securities , Ltd.#15 · 232 sh | 232 | $167.00 | — | +121.0% |
| 16 | DUPONT CAPITAL MANAGEMENT#16 · 170 sh | 170 | $122.00 | — | 0.0% |
| 17 | MORGAN STANLEY#17 · 150 sh | 150 | $108.00 | 0.00% | 0.0% |
| 18 | GHP Investment Advisors#18 · 95 sh | 95 | $69.00 | — | 0.0% |
| 19 | WELLS FARGO & COMPANY#19 · 90 sh | 90 | $65.00 | 0.00% | 0.0% |
| 20 | BARCLAYS PLC#20 · 59 sh | 59 | $42.00 | 0.00% | New |
| 21 | Caitong International Asset Management , Ltd#21 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
| 22 | DANSKE BANK A/S#22 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of AEON in Q2 2026 (4)
Held AEON at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd20,424 sh | 20,424 | $20.1K |
| JANE STREET GROUP16,376 sh | 16,376 | $16.1K |
| Vanguard Global Advisers102 sh | 102 | $100.00 |
| MAI Capital Management58 sh | 58 | $58.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.